Using a matrix as an educational approach to asthma

Journal of Pediatric Health Care

Volumn 17, Issue 1, 2003, Pages 3-10

  Johnson, Benay ^a,c   Wiesemann, Sandra ^b   Andersen, Jane ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Bureau of School Health ^*  (United States)

^c CHILDREN S HOSPITAL OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR STIMULATING AGENT; METHYLPREDNISOLONE; METHYLXANTHINE DERIVATIVE; MONTELUKAST; NEDOCROMIL; PREDNISOLONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ANTIASTHMATIC AGENT;

ASTHMA; BONE DISEASE; BRONCHOSPASM; DISEASE CONTROL; DISEASE SEVERITY; GROWTH DISORDER; HEALTH CARE PERSONNEL; HUMAN; INFLAMMATION; LONG TERM CARE; PATHOGENESIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SIDE EFFECT; TREATMENT PLANNING; ARTICLE; CHILD; FAMILY; METHODOLOGY; PATIENT CARE PLANNING; PATIENT EDUCATION; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; SELF CARE;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; FAMILY; HUMANS; LONG-TERM CARE; PATIENT CARE PLANNING; PATIENT EDUCATION; PRIMARY HEALTH CARE; SELF CARE;

EID: 0037271088     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1067/mph.2003.27     Document Type: Article

References (27)

1. Agertoft, L., & Pedersen, S. (1998). Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. American Journal of Respiratory Critical Care Medicine, 157, 178-183.
2. Agertoft, L., & Pedersen, S. (2000). Effects of long-term treatment with inhaled budesonide on adult height in children with asthma. New England Journal of Medicine, 343, 1064-1069.
3. Bisgaard, H. (2000). Role of leukotrienes in asthma pathophysiology. Pediatric Pulmonology, 30, 166-176.
4. Centers for Disease Control and Prevention. (1996). Asthma mortality and hospitalization among children and young adults - United States, 1980-1993. MMWR, 45, 350-353.
5. Centers for Disease Control and Prevention. (1998). Surveillance for asthma-United States, 1960-1995. MMWR, 47, 1-27.
6. Clark, N., & Zimmerman, B. (1990). A social cognitive view of self-regulated learning about health. Health Education Research, 5, 371-379.
7. Djukanovic, R., Roche, W. R., Wilson, J. W., Beasley, C. R. W., Twentyman, O. P., Howarth, P. H., et al. (1990). Mucosal inflammation in asthma. American Review of Respiratory Disease, 142, 434-457.
8. Drazen, J. M., Israel, E., & O'Bryne, P. M. (1999). Treatment of asthma with drugs modifying the leukotriene pathway. New England Journal of Medicine, 340, 197-206.
9. Dunhill, M. S. (1960). The pathology of asthma, with special reference to changes in the bronchial mucosa. Journal of Clinical Pathology, 13, 27-33.
10. Finnerty, J. P., Wood-Baker, R., Thomson, H., & Holgate, S. T. (1992). Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. American Review of Respiratory Disease, 145, 746-749.
11. Fraenkel, D. J., Bardin, P. G., Sanderson, G., Lampe, F., Johnston, S. L., & Holgate, S. T. (1995). Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects. American Journal of Respiratory Critical Care Medicine, 151, 879-886.
12. Geller, G. (1996). Acute management of severe childhood asthma. AACN Clinical Issues, 7, 519-528.
13. Ladebauche, P. (1997). Managing asthma: A growth and development approach. Pediatric Nursing, 23, 37-44.
14. Larsen, G. L., & Holt, P. G. (2000). The concept of airway inflammation.American Journal of Respiratory & Critical Care Medicine, 162(2 Pt 2), S2-S6.
15. Lazarus, S. (1998). Inflammation, inflammatory mediators, and mediator antagonists in asthma. Clinical Pharmacology, 38, 577-582.
16. Lemanske, R. F., Dick, E. C., Swenson, C. A., Vrtis, R. F., & Busse, W. W. (1989). Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. Journal of Clinical Investigation, 83, 1-10.
17. Levinson, H., Reilly, P. A., & Worsley, G. H. (1985). Spacing devices and metered-dose inhalers in childhood asthma. Journal of Pediatrics, 107, 662-668.
18. Mellins, R. B., Evans, D., Clark, N., Zimmerman, B., & Wiesemann, S. (2000). Developing and communicating a long-term treatment plan for asthma. American Family Physician, 61, 2419-2426.
19. National Heart, Lung, and Blood Institute (NHLBI). (1997). National asthma education and prevention program. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma (No. 97-4056). Bethesda, MD: Author.
20. Plaut, T. (1991). One minute asthma: What parents need to know. Amherst: Pedipress.
21. Prenner, B. M. (1982). Safety, efficacy and bronchodilators-sparing effects of nebulized cromolyn sodium solution in the treatment of asthma in children. Annals of Allergy, 49, 186-189.
22. Rachelefsky, G. S. (1995). Asthma update: New approaches and partnerships. Journal of Pediatric Health Care, 9, 12-21.
23. Rietveld, S., & Prins, P. J. (1998). The relationship between negative emotions and acute subjective and objective symptoms of childhood asthma. Psychological Medicine, 28, 407-415.
24. Russell, G., Williams, D. A. J., Weller, P., & Price, J.F. (1995). Salmeterol xinafoate in children on high-dose inhaled steroids. Annals of Allergy Asthma, & Immunology, 75, 423-428.
25. Sherman, J., & Hendeles, L. (2000). Practical pharmacotherapy for pediatric asthma. Pediatric Annals, 12, 768-773.
26. Wolthers, O. D., & Pedersen, S. (1992). Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics, 89, 839-842.
27. Yunginger, J. W., Reed, C. E., O'Connell, E. J., Melton, L. J., O'Fallon, W. M., & Silverstein, M. D. (1992). Community-based study of the epidemiology of asthma. Incidence rates 1964-1983. American Review of Respiratory Disease, 146, 888-894.